What was studied?
Twenty men with obesity, including participants with type 2 diabetes, entered a randomized, double-blind comparison of oral glutathione and placebo. Investigators used an insulin-sensitivity clamp, muscle sampling and oxidative-stress measurements.
What did the researchers report?
Insulin sensitivity increased in the glutathione group, but the measured mitochondrial hydrogen-peroxide emission and several oxidative-damage markers did not show corresponding intervention effects. The findings were not uniformly positive across endpoints.
What are the limits?
This small, three-week study cannot establish durable diabetes outcomes or general clinical effectiveness. Oral supplementation is distinct from other formulations and routes. Multiple endpoints, limited participants and short follow-up should remain visible when interpreting the result.
Original editorial summary by Sulan Peptide. Based on the source abstract; consult the full paper for methods, analyses, funding and disclosures.